long-acting opioids
FDA to Widen Opioid REMS to IR Formulations
The FDA will broaden the existing opioid REMS, which currently only covers extended-release, long-acting ...
OCTOBER 5, 2017
Long-Acting Opioids Increase Mortality Risk Over Alternative Medications
Total mortality in patients taking long-acting opioids to control noncancer pain was 64% greater than in patients ...
SEPTEMBER 15, 2016
Load more